Sara Najafi

486 total citations
22 papers, 229 citations indexed

About

Sara Najafi is a scholar working on Molecular Biology, Neurology and Infectious Diseases. According to data from OpenAlex, Sara Najafi has authored 22 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Neurology and 3 papers in Infectious Diseases. Recurrent topics in Sara Najafi's work include Neuroblastoma Research and Treatments (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Protein Degradation and Inhibitors (5 papers). Sara Najafi is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Protein Degradation and Inhibitors (5 papers). Sara Najafi collaborates with scholars based in Iran, Germany and United States. Sara Najafi's co-authors include Ina Oehme, Amirhossein Sahebkar, Heike Peterziel, Benjamin Meder, Johannes Ridinger, Mohammad Ghasemi Nour, Alexandra E. Butler, Arash Akhavan Rezayat, Frank Westermann and Olaf Witt and has published in prestigious journals such as Angewandte Chemie International Edition, Neuroscience & Biobehavioral Reviews and British Journal of Cancer.

In The Last Decade

Sara Najafi

19 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Najafi Iran 10 93 35 30 26 25 22 229
Ling Ning China 12 133 1.4× 34 1.0× 36 1.2× 25 1.0× 40 1.6× 20 334
Jiwon Jeong South Korea 11 114 1.2× 8 0.2× 32 1.1× 41 1.6× 7 0.3× 37 304
Adel Abo Mansour Saudi Arabia 8 65 0.7× 27 0.8× 15 0.5× 23 0.9× 9 0.4× 15 212
Fatemeh Seyedi Iran 11 101 1.1× 8 0.2× 9 0.3× 22 0.8× 23 0.9× 32 298
Joan Compte Spain 5 154 1.7× 25 0.7× 7 0.2× 23 0.9× 31 1.2× 7 248
Shaghayegh Norouzi Australia 10 87 0.9× 25 0.7× 4 0.1× 33 1.3× 18 0.7× 14 338
Asha Kumari India 7 119 1.3× 6 0.2× 17 0.6× 20 0.8× 27 1.1× 24 296
Shrinidh Joshi United States 8 109 1.2× 26 0.7× 23 0.8× 16 0.6× 16 0.6× 17 385
Xiaohe Zheng China 11 264 2.8× 10 0.3× 16 0.5× 10 0.4× 50 2.0× 23 467
Lishan Yang China 9 98 1.1× 6 0.2× 12 0.4× 17 0.7× 39 1.6× 23 255

Countries citing papers authored by Sara Najafi

Since Specialization
Citations

This map shows the geographic impact of Sara Najafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Najafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Najafi more than expected).

Fields of papers citing papers by Sara Najafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Najafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Najafi. The network helps show where Sara Najafi may publish in the future.

Co-authorship network of co-authors of Sara Najafi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Najafi. A scholar is included among the top collaborators of Sara Najafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Najafi. Sara Najafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdelsalam, Mohamed, Matthias Schmidt, Sara Najafi, et al.. (2025). Identification of a Proteolysis‐Targeting‐Chimera that Addresses Activated Checkpoint Kinase‐1 Reveals its Non‐Catalytic Functions in Tumor Cells. Angewandte Chemie International Edition. 64(49). e202514788–e202514788.
2.
Najafi, Sara, Mohaddeseh Sadat Alavi, & Hamid Reza Sadeghnia. (2025). A meta-analytic evaluation of the efficacy and safety of levetiracetam for treating myoclonic seizures. Heliyon. 11(3). e42244–e42244. 1 indexed citations
3.
Najafi, Sara, et al.. (2025). Exploring the impact of drug decriminalization and legalization policies on mental health outcomes: A scoping review. PLOS mental health.. 2(10). e0000358–e0000358.
4.
Abdelsalam, Mohamed, Caroline Alvares, Matthias Schmidt, et al.. (2024). Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins. Leukemia. 38(12). 2561–2572. 12 indexed citations
5.
Nguyen, Duy, Sara Najafi, Norman Mack, et al.. (2024). Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours. British Journal of Cancer. 131(4). 763–777. 1 indexed citations
6.
Mlakar, Vid, et al.. (2024). Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11. Frontiers in Oncology. 14. 1433256–1433256. 2 indexed citations
7.
Uher, Rudolf, Barbara Pavlová, Sara Najafi, et al.. (2024). Antecedents of major depressive, bipolar, and psychotic disorders: A systematic review and meta-analysis of prospective studies. Neuroscience & Biobehavioral Reviews. 160. 105625–105625. 16 indexed citations
8.
9.
Ridinger, Johannes, et al.. (2022). Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model. Methods in molecular biology. 2589. 75–85. 1 indexed citations
10.
Najafi, Sara, et al.. (2022). The effect of glucagon‐like peptide‐1 receptor agonists on serum uric acid concentration: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 88(8). 3627–3637. 20 indexed citations
11.
Najafi, Sara, et al.. (2021). Meningitis induced by severe acute respiratory syndrome coronavirus 2: A case report. Iranian Red Crescent Medical Journal. 1 indexed citations
12.
Najafi, Sara, et al.. (2021). Incidence of infectious diseases after earthquakes: a systematic review and meta-analysis. Public Health. 202. 131–138. 14 indexed citations
13.
14.
Najafi, Sara, et al.. (2021). A Bizarre Case of Anaphylaxis due to Hydatid Cyst Perforation Presented as Respiratory Arrest: A Case Report. International journal of pediatrics. 9(6). 13811–13815. 2 indexed citations
15.
Rezayat, Arash Akhavan, Mohammad Ghasemi Nour, Sara Najafi, et al.. (2021). Administration of Silver Nanoparticles in Diabetes Mellitus: A Systematic Review and Meta-analysis on Animal Studies. Biological Trace Element Research. 200(4). 1699–1709. 26 indexed citations
16.
17.
Rezayat, Arash Akhavan, et al.. (2021). Mortality risk factors in kidney‐transplanted patients with COVID‐19: A systematic review and regression analysis. Health Science Reports. 4(4). e427–e427. 6 indexed citations
18.
Ridinger, Johannes, Damir Krunic, Sara Najafi, et al.. (2021). Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma. Cells. 10(5). 1001–1001. 25 indexed citations
19.
Wrobel, Jagoda K., Sara Najafi, Damir Krunic, et al.. (2020). Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts. Pharmaceuticals. 13(11). 345–345. 22 indexed citations
20.
Shen, Jing, Sara Najafi, Sina Stäble, et al.. (2018). A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment. Cell Death and Differentiation. 25(12). 2053–2070. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling Ning Breakdown of academic impact, for papers by Jiwon Jeong Breakdown of academic impact, for papers by Adel Abo Mansour Breakdown of academic impact, for papers by Fatemeh Seyedi Breakdown of academic impact, for papers by Joan Compte Breakdown of academic impact, for papers by Shaghayegh Norouzi Breakdown of academic impact, for papers by Asha Kumari Breakdown of academic impact, for papers by Shrinidh Joshi Breakdown of academic impact, for papers by Xiaohe Zheng Breakdown of academic impact, for papers by Lishan Yang
Rankless by CCL
2026